The human gut is populated by a rich and diverse microbiota that has been described as a human metabolic organ. Its composition has an impact on the health status of the host and could be the target or effector of dietary health effects. The advent of high-throughput sequencing technologies and their integration with advanced analysis methods enables the development of new approaches to characterize the gut microbiota composition and initiates the understanding of its functionality. These technological aspects are not necessarily the limiting factor to successfully identify biological correlations between gut microbiota, diet and health status, as there are other very important aspects. The aim of this article is to address the gut microbiota characterization methodologies, highlight some advantages and challenges, and give our opinion on how critical the sampling and the study design are.
The impact of dietary intervention on human health status is of major interest to the food industry. In the past couple of decades, the gut microbiota composition has gained more attention with the development of non-culture-related techniques. It is generally accepted that microbiota participates in key vital functions of the human body, and contributes to health balance [1] . From a nutritional perspective, it is potentially easier to affect human health balance by modulating its gut microbiota than acting on human genetic background. A better knowledge of gut microbiota relationship with its host is needed knowing that the human digestive tract is partitioned into segments populated with various types and amounts of bacteria ranging from 10 2 to 10 11 cells/ ml [2] . The comprehensiveness of the gut microbiota characterization has been deeply linked to the development of new sequencing techniques. The latest developments use sequencing to characterize the taxonomic diversity or the functionality of the microbiota.
As a general approach, the small subunit rRNA gene (16S gene) is targeted for microbiota phylogeny inference as well as microbial taxonomy and identification. This is currently done either by qPCR, clone libraries or sequencing of variable regions using next-generation sequencing techniques (the most widely used sequencing technique today being 454 pyrosequencing). All these techniques are based on PCR and are subject to bias. Primers are designed on current sequence knowledge as found in public databases containing 16S genes from type strains, uncultured bacteria and from annotated bacterial sequences [Ribosomal Database Project, RDP [3] , SILVA (from Latin silva, forest [4] )], and it is therefore difficult to estimate the coverage rate of the true bacterial population. For a given species of interest, qPCR has the advantage to provide accurate quantification whereas 16S pyrosequencing or clone libraries will only give relative proportions. On the other hand, clone libraries and pyrosequencing are more appropriate to obtain a broad picture at various upper taxonomic levels. The development of next-generation sequencing techniques allows a tremendous reduction in terms of costs and time to generate the raw data, making the 16S clone libraries at least 10 times more expensive in comparison, according to our experience.
Several bioinformatics tools have been developed to handle the large amount of data from initial quality check up to final classification. In the case of clone libraries and 16S pyrosequencing, it is generally performed in two ways: taxonomic classification or Operational Taxonomic Units (OTUs) clustering. The taxonomic classification may be carried out using sequence similarity search like Basic Local Alignment Search Tool (BLAST) [5] , using multiple alignment and phylogenetic assignment (ARB from Latin arbor, tree, [6] ), or using Bayesian approach like the RDP Classifier Tool [7] . In any case, all these methods rely on publicly available annotation of the 16S gene. As most of the bacteria populating the gut are anaerobes [8] , they are difficult to cultivate and to systematically characterize. Hence, a large proportion of the sequences are not assigned to a taxonomic level. This implies that the number of unclassified sequences increases with the depth of the taxonomic classification. A way to circumvent this limitation is to cluster sequences by OTUs. The general approach is to generate a multiple alignment of all the sequences and its related distance matrix using tools such as MAFFT (Multiple Alignment using Fast Fourier Transform) [9] or MUSCLE (multiple sequence comparison by log-expectation) [10] , and set an identity threshold to cluster the sequences together. The most commonly used program for assigning OTUs is DOTUR (Distance Based OTU and Richness determination) [11] . The advantage of OTUs is that they also allow computation of richness and diversity indicators that are generally used to estimate the community coverage. These two indicators are plotted as function of the number of sequences, producing rarefaction curves. The rarefaction curves are used to answer a simple question: is the current sampling reflecting the actual diversity of the population considered? Since the objective is to study the relative distribution of bacteria and estimate the diversity, it is important to plan the sequencing effort that should be made for the targeted taxonomic level.
Unlike clone libraries, which target the full 16S gene, the specificity of next-generation sequencing techniques applied to microbiota characterization is that only specific regions of the 16S genes are sequenced by designing primers in the interspaced conserved regions. Depending on the laboratory, different variable regions are targeted: V2 [12] , V1-V2 [13] , V1-V3 [14] , V4 [15] , V4-V5 [16] and V6 [17] . As shown by Wang et al. [7] , the classification accuracy varies according to the variable region chosen. Claesson et al. [16] demonstrated that this affects the results obtained and, in their study, the V4/V5 regions showed the highest classification accuracies whereas V3/V4 showed poorer classification due to PCR bias associated with the experimental amplification process.
The abovementioned techniques allow the identification of the bacteria present in a given microbiota environment. However, only hypotheses on the metabolic capabilities can be derived from the presence of specific subpopulations. To understand the potential functionalities of the microbial community in different parts of the gut, it seems that a culture-independent technique that allows direct whole-bacteria genomic-DNA sequencing, such as the metagenomics approach, would be recommended. Unlike the 16S identification, the metagenomics method has no prior PCR step making the technique more unsupervised.
Today, with the development of new sequencing techniques (e.g. sequencing by ligation, by synthesis or by semiconductor), the price is drastically reduced making the field even more attractive. For instance, recent metagenomics studies in the field of gut microbiota are not only being applied to the description of metabolic capabilities, but also to the study of pathologies such as obesity [18] and diabetes [19] , and even extended to the understanding of the human gut population of viruses [20] . From the metabolic capabilities point of view, Qin et al. [21] have described the strategy of using metagenomics with short read sequences to establish a gene catalogue of the human gut microbiome and to identify bacterial functions for life in the gut environment. Another illustration is obesity: a major public health issue very relevant for nutritional applications. It is generally accepted that one of the primary causes of obesity is the disequilibrium between caloric intake and expenditure. It is also described that obesity is associated with phylum-level changes in the microbiota and reduced bacterial diversity [17] . The hypothesis supported by Turnbaugh et al. [22] links obese individuals' microbiota with greater ability to extract energy from their diet and to deposit that energy in fat, defining a core gut microbiome at the level of metabolic functions rather than at the organismal level, and deviations from this core are associated with different physiologic states (obese versus lean).
The expansion of the gut metagenomics to all these applications is not possible without the development of bioinformatics tools that closely follow the development of the sequencing techniques [23] [24] [25] [26] [27] [28] [29] . Bioinformatics faces new demands in interpreting voluminous, noisy and often partial sequence data. Starting from large amounts of heterogeneous data (10-10 000 species), and prior to interpretation of the microbiota metabolic capabilities, several steps of analysis are required: assembly, detection of Open Reading Frames (ORF), functional annotation of predicted genes and metabolic pathway analysis. Each of these steps, at the level of several thousands of genomes sequenced, becomes a computational challenge in terms of data generation (279 gigabases from the cow rumen metagenome [30] , 567.7 gigabases from the human gut microbiome [21] ), data curation and analysis. As described by Wooley et al. [31] , numerous tools are available to perform each of these steps. It is important to keep in mind that the final annotations deeply rely on current available information in databases and that, like for 16S analyses, a large amount of non-annotated genes will be obtained with this method since complete uncultured bacterial reference sequences are missing in databases. We believe that, in the near future, complete pipelines will be made available for automatic analysis of metagenomics data similar to the 16S identification. The added value of the bioinformatics expertise is to have a critical eye on each step of a pipeline, to finely tune the parameters and to understand the pros and cons of the algorithms used and the results obtained.
An increasing amount of articles and reviews are gathering results on the role of gut microbiota. As described by Delzenne and Cani [32] , inconsistencies in the results are also highlighted. Reasons for these could be the technology used (qPCR, clone libraries, 454 pyrosequencing . . .), the 16S variable regions targeted, the primer bias, the software pipeline used, the lack of robust statistics [33] or the sampling (biological replicates, the size of cohorts [34] , the sequencing depth [21] or the area of the gut studied [35] ). In our opinion, all these parameters make the design of the study critical and should be taken into account. For instance, a recent publication from the MetaHit consortium showed that, by combining several studies on humans from various parts of the world, the microbiota could be clustered into three different enterotypes [34] (the first enriched in Bacteriodetes and Parabacteroidetes, the second enriched in Prevotella and Desulfovibrio, and the third enterotype enriched in Ruminococcus and Akkermansia). This type of analysis demonstrates that the wider the cohort, the more reliable the differences are.
The rapid evolution of the technologies (sequencing, software solutions, computer power and storage) opens the door for nutritionists, microbiologists, physicians to work together for better understanding the gut ecology and its impact on human health.
Key Points
The fast progress of new sequencing techniques followed by the rapid development of bioinformatics solutions opens the door to topics of research unexplored until recently in the field of gut microbiota characterization. In this opinion article, we summarize the available methods for microbiota characterization and we describe the advantages and limitations of these methods. Finally, we draw attention to the importance of study design to avoid results inconsistencies or biased results.
